153 related articles for article (PubMed ID: 17157812)
1. Kv1.3/Kv1.5 heteromeric channels compromise pharmacological responses in macrophages.
Villalonga N; Escalada A; Vicente R; Sánchez-Tilló E; Celada A; Solsona C; Felipe A
Biochem Biophys Res Commun; 2007 Jan; 352(4):913-8. PubMed ID: 17157812
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory effects of diclofenac in leukocytes through the targeting of Kv1.3 voltage-dependent potassium channels.
Villalonga N; David M; Bielańska J; González T; Parra D; Soler C; Comes N; Valenzuela C; Felipe A
Biochem Pharmacol; 2010 Sep; 80(6):858-66. PubMed ID: 20488163
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
Grissmer S; Nguyen AN; Aiyar J; Hanson DC; Mather RJ; Gutman GA; Karmilowicz MJ; Auperin DD; Chandy KG
Mol Pharmacol; 1994 Jun; 45(6):1227-34. PubMed ID: 7517498
[TBL] [Abstract][Full Text] [Related]
4. Association of Kv1.5 and Kv1.3 contributes to the major voltage-dependent K+ channel in macrophages.
Vicente R; Escalada A; Villalonga N; Texidó L; Roura-Ferrer M; Martín-Satué M; López-Iglesias C; Soler C; Solsona C; Tamkun MM; Felipe A
J Biol Chem; 2006 Dec; 281(49):37675-85. PubMed ID: 17038323
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulation of voltage-dependent K+ channels in macrophages: molecular and biophysical consequences.
Villalonga N; David M; Bielanska J; Vicente R; Comes N; Valenzuela C; Felipe A
J Gen Physiol; 2010 Feb; 135(2):135-47. PubMed ID: 20100893
[TBL] [Abstract][Full Text] [Related]
6. A selective blocker of Kv1.2 and Kv1.3 potassium channels from the venom of the scorpion Centruroides suffusus suffusus.
Corzo G; Papp F; Varga Z; Barraza O; Espino-Solis PG; Rodríguez de la Vega RC; Gaspar R; Panyi G; Possani LD
Biochem Pharmacol; 2008 Oct; 76(9):1142-54. PubMed ID: 18786511
[TBL] [Abstract][Full Text] [Related]
7. Anuroctoxin, a new scorpion toxin of the alpha-KTx 6 subfamily, is highly selective for Kv1.3 over IKCa1 ion channels of human T lymphocytes.
Bagdány M; Batista CV; Valdez-Cruz NA; Somodi S; Rodriguez de la Vega RC; Licea AF; Varga Z; Gáspár R; Possani LD; Panyi G
Mol Pharmacol; 2005 Apr; 67(4):1034-44. PubMed ID: 15615696
[TBL] [Abstract][Full Text] [Related]
8. T-lymphocyte calcium influx characteristics and their modulation by Kv1.3 and IKCa1 channel inhibitors in the neonate.
Toldi G; Treszl A; Pongor V; Gyarmati B; Tulassay T; Vásárhelyi B
Int Immunol; 2010 Sep; 22(9):769-74. PubMed ID: 20601376
[TBL] [Abstract][Full Text] [Related]
9. A new Kaliotoxin selective towards Kv1.3 and Kv1.2 but not Kv1.1 channels expressed in oocytes.
Abbas N; Belghazi M; Abdel-Mottaleb Y; Tytgat J; Bougis PE; Martin-Eauclaire MF
Biochem Biophys Res Commun; 2008 Nov; 376(3):525-30. PubMed ID: 18804453
[TBL] [Abstract][Full Text] [Related]
10. Functional consequences of Kv1.3 ion channel rearrangement into the immunological synapse.
Tóth A; Szilágyi O; Krasznai Z; Panyi G; Hajdú P
Immunol Lett; 2009 Jun; 125(1):15-21. PubMed ID: 19477198
[TBL] [Abstract][Full Text] [Related]
11. Kv1.3 potassium channels as a therapeutic target in multiple sclerosis.
Rangaraju S; Chi V; Pennington MW; Chandy KG
Expert Opin Ther Targets; 2009 Aug; 13(8):909-24. PubMed ID: 19538097
[TBL] [Abstract][Full Text] [Related]
12. The investigation of interactions of kappa-Hefutoxin1 with the voltage-gated potassium channels: a computational simulation.
Zarrabi M; Naderi-Manesh H
Proteins; 2008 May; 71(3):1441-9. PubMed ID: 18076029
[TBL] [Abstract][Full Text] [Related]
13. Minocycline decreases in vitro microglial motility, beta1-integrin, and Kv1.3 channel expression.
Nutile-McMenemy N; Elfenbein A; Deleo JA
J Neurochem; 2007 Dec; 103(5):2035-46. PubMed ID: 17868321
[TBL] [Abstract][Full Text] [Related]
14. Developmental switch of the expression of ion channels in human dendritic cells.
Zsiros E; Kis-Toth K; Hajdu P; Gaspar R; Bielanska J; Felipe A; Rajnavolgyi E; Panyi G
J Immunol; 2009 Oct; 183(7):4483-92. PubMed ID: 19748986
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte activation in type 1 diabetes mellitus: the increased significance of Kv1.3 potassium channels.
Toldi G; Vásárhelyi B; Kaposi A; Mészáros G; Pánczél P; Hosszufalusi N; Tulassay T; Treszl A
Immunol Lett; 2010 Sep; 133(1):35-41. PubMed ID: 20603149
[TBL] [Abstract][Full Text] [Related]
16. Induction of apoptosis in macrophages via Kv1.3 and Kv1.5 potassium channels.
Leanza L; Zoratti M; Gulbins E; Szabò I
Curr Med Chem; 2012; 19(31):5394-404. PubMed ID: 22856664
[TBL] [Abstract][Full Text] [Related]
17. Kv1.5 association modifies Kv1.3 traffic and membrane localization.
Vicente R; Villalonga N; Calvo M; Escalada A; Solsona C; Soler C; Tamkun MM; Felipe A
J Biol Chem; 2008 Mar; 283(13):8756-64. PubMed ID: 18218624
[TBL] [Abstract][Full Text] [Related]
18. The potassium channels Kv1.5 and Kv1.3 modulate distinct functions of microglia.
Pannasch U; Färber K; Nolte C; Blonski M; Yan Chiu S; Messing A; Kettenmann H
Mol Cell Neurosci; 2006 Dec; 33(4):401-11. PubMed ID: 17055293
[TBL] [Abstract][Full Text] [Related]
19. Emerging role for the voltage-dependent K+ channel Kv1.5 in B-lymphocyte physiology: expression associated with human lymphoma malignancy.
Vallejo-Gracia A; Bielanska J; Hernández-Losa J; Castellví J; Ruiz-Marcellan MC; Ramón y Cajal S; Condom E; Manils J; Soler C; Comes N; Ferreres JC; Felipe A
J Leukoc Biol; 2013 Oct; 94(4):779-89. PubMed ID: 23847097
[TBL] [Abstract][Full Text] [Related]
20. Biophysical and pharmacological aspects of K+ channels in T lymphocytes.
Panyi G
Eur Biophys J; 2005 Aug; 34(6):515-29. PubMed ID: 16184309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
